Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1710839

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1710839

Global Eubiotics Market Size study, by Type, by Livestock, by Form, by Function and Regional Forecasts 2022-2032

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

Global Eubiotics Market is valued at approximately USD 8.04 billion in 2023 and is projected to grow at a healthy CAGR of more than 7.51% over the forecast period 2024-2032. Eubiotics, encompassing a spectrum of probiotics, prebiotics, organic acids, and essential oils, are redefining animal nutrition by fostering a healthy balance of gut microflora and reducing dependency on synthetic growth promoters. As the livestock sector undergoes a paradigm shift toward sustainable production and antibiotic-free animal husbandry, the demand for eubiotics has surged exponentially. These bioactive compounds not only enhance digestive function and nutrient absorption but also fortify the immune system, leading to improved yield and quality of meat, milk, and eggs.

The steady rise in global meat consumption, coupled with regulatory crackdowns on antimicrobial usage in livestock, is propelling the eubiotics market forward. Livestock producers are embracing these alternatives to safeguard animal health, increase productivity, and meet evolving consumer preferences for clean-label, traceable protein. Eubiotics have become essential across various livestock categories-boosting feed efficiency in swine and poultry, improving rumen fermentation in ruminants, and enhancing disease resistance in aquaculture. This broad-spectrum applicability, combined with growing awareness about gut-health-centric farming, is catalyzing product innovation and diversified eubiotic formulations tailored to species-specific physiological needs.

Advancements in biotechnology, including microencapsulation, pH-targeted release systems, and next-gen microbial strains, are revolutionizing the delivery and efficacy of eubiotics. Manufacturers are actively investing in R&D to formulate multi-functional blends that synergize probiotics with essential oils or organic acids, offering holistic benefits such as improved gut integrity, pathogen inhibition, and stress mitigation. Additionally, partnerships between feed additive companies and animal health specialists are enabling the development of data-driven supplementation strategies that align with performance benchmarks, climate variability, and feed composition shifts, reinforcing the market's upward trajectory.

Europe currently dominates the global eubiotics market landscape, supported by stringent EU regulations on antibiotic use, well-established animal feed infrastructure, and a consumer base that values food quality and traceability. North America follows closely, with rapid technological adoption in livestock health management and rising demand for functional ingredients in animal nutrition. Meanwhile, Asia Pacific is anticipated to exhibit the fastest growth through 2032, driven by burgeoning livestock populations, rising protein consumption, and evolving regulatory standards in countries such as China, India, and Vietnam. Latin America and the Middle East & Africa are steadily gaining ground, fueled by increasing exports of animal protein and shifting focus toward efficient and ethical animal farming practices.

Major market player included in this report are:

  • Novus International Inc.
  • ADM (Archer Daniels Midland Company)
  • DSM Nutritional Products AG
  • Kemin Industries, Inc.
  • BASF SE
  • Cargill, Incorporated
  • Lallemand Inc.
  • CHR Hansen Holdings A/S
  • Evonik Industries AG
  • Alltech Inc.
  • Lesaffre Group
  • Phileo by Lesaffre
  • Yara International ASA
  • Biomin GmbH
  • Anpario PLC

The detailed segments and sub-segment of the market are explained below:

By Type

  • Probiotics
  • Prebiotics
  • Organic Acids
  • Essential Oils

By Livestock

  • Swine
  • Poultry
  • Ruminant
  • Aquaculture

By Form

  • Dry
  • Liquid

By Function

  • Nutrition & Gut Health
  • Yield
  • Immunity
  • Production

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Eubiotics Market Executive Summary

  • 1.1. Global Eubiotics Market Size & Forecast (2022 2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Type
    • 1.3.2. By Livestock
    • 1.3.3. By Form & Function
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Eubiotics Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Producer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Producer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Eubiotics Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Regulatory bans on antibiotic growth promoters
    • 3.1.2. Rising demand for antibiotic alternative feed solutions
    • 3.1.3. Emphasis on gut health centric productivity
  • 3.2. Market Challenges
    • 3.2.1. Volatility in raw material supply and costs
    • 3.2.2. Standardization of bioactive content across products
    • 3.2.3. Need for species and region specific formulations
  • 3.3. Market Opportunities
    • 3.3.1. Advances in microencapsulation and targeted release
    • 3.3.2. Synergistic blends with probiotics and essential oils
    • 3.3.3. Data driven supplementation via digital feeding platforms

Chapter 4. Global Eubiotics Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's Model
    • 4.1.7. Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunity
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Eubiotics Market Size & Forecasts by Type and Livestock 2022 2032

  • 5.1. Segment Dashboard
  • 5.2. Global Market: Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.2.1. Probiotics
    • 5.2.2. Prebiotics
    • 5.2.3. Organic Acids
    • 5.2.4. Essential Oils
  • 5.3. Global Market: Livestock Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 5.3.1. Swine
    • 5.3.2. Poultry
    • 5.3.3. Ruminant
    • 5.3.4. Aquaculture

Chapter 6. Global Eubiotics Market Size & Forecasts by Form and Function 2022 2032

  • 6.1. Segment Dashboard
  • 6.2. Global Market: Form Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.2.1. Dry
    • 6.2.2. Liquid
  • 6.3. Global Market: Function Revenue Trend Analysis, 2022 & 2032 (USD Billion)
    • 6.3.1. Nutrition & Gut Health
    • 6.3.2. Yield
    • 6.3.3. Immunity
    • 6.3.4. Production

Chapter 7. Global Eubiotics Market Size & Forecasts by Region 2022 2032

  • 7.1. North America Market
    • 7.1.1. U.S. Market
      • 7.1.1.1. Type & Livestock breakdown, 2022 2032
    • 7.1.2. Canada Market
  • 7.2. Europe Market
    • 7.2.1. UK Market
    • 7.2.2. Germany Market
    • 7.2.3. France Market
    • 7.2.4. Spain Market
    • 7.2.5. Italy Market
    • 7.2.6. Rest of Europe Market
  • 7.3. Asia Pacific Market
    • 7.3.1. China Market
    • 7.3.2. India Market
    • 7.3.3. Japan Market
    • 7.3.4. Australia Market
    • 7.3.5. South Korea Market
    • 7.3.6. Rest of Asia Pacific Market
  • 7.4. Latin America Market
    • 7.4.1. Brazil Market
    • 7.4.2. Mexico Market
    • 7.4.3. Rest of Latin America Market
  • 7.5. Middle East & Africa Market
    • 7.5.1. Saudi Arabia Market
    • 7.5.2. South Africa Market
    • 7.5.3. Rest of Middle East & Africa Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. Novus International Inc.
    • 8.1.2. ADM (Archer Daniels Midland Company)
    • 8.1.3. DSM Nutritional Products AG
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Novus International Inc.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. ADM (Archer Daniels Midland Company)
    • 8.3.3. DSM Nutritional Products AG
    • 8.3.4. Kemin Industries, Inc.
    • 8.3.5. BASF SE
    • 8.3.6. Cargill, Incorporated
    • 8.3.7. Lallemand Inc.
    • 8.3.8. CHR Hansen Holdings A/S
    • 8.3.9. Evonik Industries AG
    • 8.3.10. Alltech Inc.
    • 8.3.11. Lesaffre Group
    • 8.3.12. Phileo by Lesaffre
    • 8.3.13. Yara International ASA
    • 8.3.14. Biomin GmbH
    • 8.3.15. Anpario PLC

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!